New Developments in OncologyAddressing Novel Therapies In Oncology & Hematology

SATURDAY, NOVEMBER 9, 2019 | 7:00 AM – 3:30 PMHilton Norfolk the Main | 100 East Main Street | Norfolk, Virginia

PRESENTED BY:

Virginia Oncology Associates 20th Annual Conference

Scott Antonia, MD, PhD Instructor, Temporary, Division of Medical OncologyDirector, DCI Center for Cancer ImmunotherapyDuke University Health System

Susan Dent, MD, FRCPC Instructor, Temporary, Department of Medicine Associate Director of Breast Cancer Clinical Research Co-Director Duke Cardio-Oncology Program Duke University Health System

Robert Dreicer, MD, MS Section Head, Medical OncologyDeputy Director, University of Virginia Cancer Center

Carolyn Krisko, RN, OCNClinical Nurse IIDuke University Health System

Nicole Kuderer, MD, PhD Chief Medical O­cer, Advanced Cancer Research GroupFred Hutchinson Cancer Research CenterSeattle, Washington

Bernadette Labriola, FNP-C, MSN, RN Nurse PractitionerDuke University Health System

Gary H Lyman, MD, MPH Professor of Medicine University of Washington School of MedicineFred Hutchinson Cancer Research Center

Jeffrey Weber, MD, PhD Deputy Director and Head, Experimental TherapeuticsLaura and Isaac Perlmutter Comprehensive Cancer Center

Now in its 20th year, New Developments in Oncology has o�ered a comprehensive view of advancements in treatments, techniques, and technologies for treating and managing cancer and blood diseases, as well as related symptoms. With a focus on the impact of biosimilars on health care delivery and outcomes, experts from across the country will engage in discussion of the state of the science and management of patients with thoracic

FACULTYPresenting

malignancies, prostate cancers, and thrombosis. New this year, through a collaborative, concerted e�ort between expert doctors and nurses, the Duke Cancer Network and Virginia Oncology Associates are excited to emphasize inter-professional approaches to cancer care, specifically in the management of patients with malignant melanoma and breast cancer.

7:00 am – 7:55 am Breakfast / Registration

7:55 am – 8:00 am Welcome / Introductions Edward George, MD, FACP

8:00 am – 9:00 am Keynote Address Opportunities, Challenges, and Impact of the Evolving Biosimilar Revolution in Oncology Gary Lyman, MD, MPH

9:00 am – 9:45 am The Rapidly Evolving Field of Melanoma Research and Treatment Je�rey Weber, MD, PhD

9:45 am – 10:00 am The Rapidly Evolving Field of Melanoma Research and Treatment: 2019 Nursing Implications Carolyn Krisko, RN, OCN

10:00 am – 10:30 am Break

10:30 am – 11:30 am An Update of Thrombosis in Malignancy: Predictors of Progression and Mortality, and Thromboprophylaxis Nicole Kuderer, MD, PhD

11:30 am – 12:30 pm The Latest Developments in the Research and Management of Thoracic Oncology Scott Antonia, MD, PhD

12:30 pm – 1:30 pm Lunch

1:30 pm – 2:30 pm Progress in the Research and Management of Prostate Cancer Robert Dreicer, MD, MS

2:30 pm – 3:15 pm Breast Cancer Update: 2019 Susan Dent, MD, FRCPC

3:15 pm – 3:30 pm Breast Cancer Update: 2019 Nursing Implications Bernadette Labriola, FNP-C, MSN, RN

3:30 pm Wrap Up

A brief question & answer period willfollow each speaker’s presentation.

AGENDANovember 9, 2019

Conference

OBJECTIVES· Discuss emerging research in the management of cancer.

· Review current evidence- based best practices in the management of cancer.

· Examine the impact of biosimilars in cancer treatment.

· Highlight new concepts and latest developments in the management of thrombosis, breast cancer, thoracic malignancies, prostate cancer, and malignant melanoma.

ACCREDITATION

In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Physicians: Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nursing: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 6 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

Pharmacists: Duke University Health System Department ofClinical Education and Professional Development designates this activity for up to 6 ACPE credit hours. Universal Activity Numbers: JA0000655-0000-19-272-L01-P\T.

This activiy has been approved for ASRT.

SPECIAL NEEDS STATEMENT

Duke Cancer Network is committed to making its activitiesaccessible to all individuals. If you are in need of anaccommodation, please do not hesitate to call and/or submit a description of your needs in writing in order to receive service.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity will be supported in part by exhibitor support. A complete list of supporters will be acknowledged at the conference.

DISCLAIMERThe information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a health care provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Learning

REGISTRATIONNew Developmentsin Oncology:Addressing Novel Therapiesin Oncology & Hematology

Hilton Norfolk The Main100 East Main Street Norfolk, Virginia 23510

Online Registration:Register online at:https://goo.gl/TmqV4z

Conference Registration Deadline:Friday, November 1, 2019

Registration Fee:Physicians: $75.00Fellows, Nurses,Pharmacists, PA, NP: $50.00Industry Professionals(Not covered by exhibit fee): $600

Hotel Registration Deadline:Friday, October 18, 2019

If you have any questions or concerns, please contact Beth Tanner at(919) 681-9869 or beth.tanner@duke.edu.

Hilton Norfolk The Main100 East Main Street | Norfolk, Virginia 23510

Hilton Norfolk The Main o�ers impeccable full-service hospitality and amenities. This modern luxury hotel sits along the downtown Norfolk waterfront with quick access to cultural attractions, trendy shopping and dining. GROUP RESERVATION INFORMATION | VIRGINIA ONCOLOGY

Dates: Friday, November 8, 2019 - Sunday, November 10, 2019Group Name: Virginia Oncology AssociatesGroup Code: VONGroup Rate: $159Rate Available Until: Friday, October 18, 2019Deposit: One night deposit required at time of reservation

GUESTROOM RESERVATIONS BY PHONE

Guests may make reservations by calling the Hilton Norfolk The Main directlyat 757-763-6200 and requesting to speak with the In-House ReservationDepartment or by calling Hilton Central Reservations at 1-800-HILTONS.Attendees should identify themselves as part of the Virginia OncologyAssociates conference and the group code is VON.

GUESTROOM RESERVATIONS ONLINE

Reservations may be made online at the hotel’s website - https://bit.ly/2GbBMyU.

Hilton

11.9.2019

For 20 years, New Developments in Oncology has o�ered a comprehensive view of advancements in treatments,

techniques and technologies for treating and managing cancer and blood diseases, as well as related

symptoms. This event is presented by Duke Cancer Network and Virginia

Oncology Associates.

Duke Cancer Network Attn: Beth TannerDUMC 3326Durham, NC 27710